-
-
-
-
-
-
-
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
-
-
-
-
-
-
-
Jefferies sees Dyne as key beneficiary of Novartis’ Avidity buyout
-
-
-
-
-
-
-
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
-
-
-
-
-
-
-
ERYTECH Appoints New Independent Board Member
-
-
-
-
-
-
-
Prosensa (RNA) Holders Approve Certain Items Related to BioMarin (BMRN) Transaction
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 11/24: (BMRN) (CIMT) (SYN) Higher; (CANF) (GALE) (BIND) Lower
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 05/23: (LIVE) (PTCT) (YOD) Higher; (ARO) (TGEN) (COVS) Lower
-
1,201,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


